Loading…

Cardiac involvement in a case of juvenile dermatomyositis with positive anti‐melanoma differentiation associated protein 5 antibody

Juvenile dermatomyositis (JDM) is an autoimmune disease characterized by muscle weakness and specific skin lesions, as well as non‐muscular involvement such as interstitial lung disease (ILD), cardiac involvement and arthritis. Anti‐melanoma differentiation‐associated protein 5 (anti‐MDA5)‐positive...

Full description

Saved in:
Bibliographic Details
Published in:International journal of rheumatic diseases 2023-08, Vol.26 (8), p.1582-1585
Main Authors: Kaplan, Melike Mehveş, Çelikel, Elif, Güngörer, Vildan, Ekici Tekin, Zahide, Gürsu, Hazım Alper, Polat, Sanem Eryılmaz, Cinel, Güzin, Çelikel Acar, Banu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3380-32f1a8a0a544d20f15a85f2359ff120dd7813b2905859604804282dbc1f074343
cites cdi_FETCH-LOGICAL-c3380-32f1a8a0a544d20f15a85f2359ff120dd7813b2905859604804282dbc1f074343
container_end_page 1585
container_issue 8
container_start_page 1582
container_title International journal of rheumatic diseases
container_volume 26
creator Kaplan, Melike Mehveş
Çelikel, Elif
Güngörer, Vildan
Ekici Tekin, Zahide
Gürsu, Hazım Alper
Polat, Sanem Eryılmaz
Cinel, Güzin
Çelikel Acar, Banu
description Juvenile dermatomyositis (JDM) is an autoimmune disease characterized by muscle weakness and specific skin lesions, as well as non‐muscular involvement such as interstitial lung disease (ILD), cardiac involvement and arthritis. Anti‐melanoma differentiation‐associated protein 5 (anti‐MDA5)‐positive JDM patients are typically characterized by the presence of skin ulcers and rapidly progressing ILD (RP‐ILD). Although cardiac involvement is not an expected involvement in anti‐MDA5‐positive JDM cases, it is significant because it can be fatal. In this report, an anti‐MDA5 myositis‐specific autoantibody‐positive JDM case referred with the diagnosis of psoriatic arthritis in whom cardiomyopathy and arrhythmia were detected in follow‐up is presented. Since cardiac involvement is associated with mortality, it would be useful to follow up anti‐MDA5 positive patients for cardiac involvement in addition to lung involvement. Tofacitinib is a promising treatment option in treatment‐resistant JDM.
doi_str_mv 10.1111/1756-185X.14630
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2844142270</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2844142270</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3380-32f1a8a0a544d20f15a85f2359ff120dd7813b2905859604804282dbc1f074343</originalsourceid><addsrcrecordid>eNqFkLtOwzAUhi0EolCY2ZAl5rS-Ju5YVdykSjCAxGY5sS1cNXGxk1bdWNh5Rp4E90JXvPgc6z_fsT4ArjAa4HSGuOB5hgV_G2CWU3QEzg4vx4ea4R44j3GGUI5pXpyCHs0FJ6LgZ-BrooJ2qoKuWfr50tSmaVMNFaxUNNBbOOuWpnFzA7UJtWp9vfbRtS7ClWvf4WLbLA1UTet-Pr9rM1eNrxXUzloTEs2p1vkEjNFXqTYaLoJvTdrBt0Ol1-sLcGLVPJrL_d0Hr3e3L5OHbPp0_zgZT7OKUoEySixWQiHFGdMEWcyV4JZQPrIWE6R1ITAtyQhxwUc5YgIxIoguK2xRwSijfXCz46YvfHQmtnLmu9CklZIIxjAjpEApNdylquBjDMbKRXC1CmuJkdxolxuxciNZbrWnies9tytrow_5P88pwHeBVTK5_o8nx8_THfgXKyqPIg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844142270</pqid></control><display><type>article</type><title>Cardiac involvement in a case of juvenile dermatomyositis with positive anti‐melanoma differentiation associated protein 5 antibody</title><source>Wiley</source><creator>Kaplan, Melike Mehveş ; Çelikel, Elif ; Güngörer, Vildan ; Ekici Tekin, Zahide ; Gürsu, Hazım Alper ; Polat, Sanem Eryılmaz ; Cinel, Güzin ; Çelikel Acar, Banu</creator><creatorcontrib>Kaplan, Melike Mehveş ; Çelikel, Elif ; Güngörer, Vildan ; Ekici Tekin, Zahide ; Gürsu, Hazım Alper ; Polat, Sanem Eryılmaz ; Cinel, Güzin ; Çelikel Acar, Banu</creatorcontrib><description>Juvenile dermatomyositis (JDM) is an autoimmune disease characterized by muscle weakness and specific skin lesions, as well as non‐muscular involvement such as interstitial lung disease (ILD), cardiac involvement and arthritis. Anti‐melanoma differentiation‐associated protein 5 (anti‐MDA5)‐positive JDM patients are typically characterized by the presence of skin ulcers and rapidly progressing ILD (RP‐ILD). Although cardiac involvement is not an expected involvement in anti‐MDA5‐positive JDM cases, it is significant because it can be fatal. In this report, an anti‐MDA5 myositis‐specific autoantibody‐positive JDM case referred with the diagnosis of psoriatic arthritis in whom cardiomyopathy and arrhythmia were detected in follow‐up is presented. Since cardiac involvement is associated with mortality, it would be useful to follow up anti‐MDA5 positive patients for cardiac involvement in addition to lung involvement. Tofacitinib is a promising treatment option in treatment‐resistant JDM.</description><identifier>ISSN: 1756-1841</identifier><identifier>EISSN: 1756-185X</identifier><identifier>DOI: 10.1111/1756-185X.14630</identifier><identifier>PMID: 36852875</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>anti‐MDA5 ; Arrhythmia ; Autoantibodies ; Autoimmune diseases ; cardiac involvement ; Cardiomyopathy ; Coronary artery disease ; Dermatomyositis ; Heart diseases ; juvenile dermatomyositis ; Lung diseases ; Melanoma ; Myositis ; Psoriatic arthritis ; Skin diseases ; Skin lesions ; Ulcers</subject><ispartof>International journal of rheumatic diseases, 2023-08, Vol.26 (8), p.1582-1585</ispartof><rights>2023 Asia Pacific League of Associations for Rheumatology and John Wiley &amp; Sons Australia, Ltd.</rights><rights>International Journal of Rheumatic Diseases © 2023 Asia Pacific League of Associations for Rheumatology and John Wiley &amp; Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3380-32f1a8a0a544d20f15a85f2359ff120dd7813b2905859604804282dbc1f074343</citedby><cites>FETCH-LOGICAL-c3380-32f1a8a0a544d20f15a85f2359ff120dd7813b2905859604804282dbc1f074343</cites><orcidid>0000-0003-0129-4410 ; 0000-0003-2309-7952 ; 0000-0002-6209-196X ; 0000-0002-0707-2678 ; 0000-0002-5446-667X ; 0000-0002-8012-2774 ; 0000-0002-9838-2603 ; 0000-0002-1808-3655</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1756-185X.14630$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1756-185X.14630$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,786,790,27957,27958,50923,51032</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36852875$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaplan, Melike Mehveş</creatorcontrib><creatorcontrib>Çelikel, Elif</creatorcontrib><creatorcontrib>Güngörer, Vildan</creatorcontrib><creatorcontrib>Ekici Tekin, Zahide</creatorcontrib><creatorcontrib>Gürsu, Hazım Alper</creatorcontrib><creatorcontrib>Polat, Sanem Eryılmaz</creatorcontrib><creatorcontrib>Cinel, Güzin</creatorcontrib><creatorcontrib>Çelikel Acar, Banu</creatorcontrib><title>Cardiac involvement in a case of juvenile dermatomyositis with positive anti‐melanoma differentiation associated protein 5 antibody</title><title>International journal of rheumatic diseases</title><addtitle>Int J Rheum Dis</addtitle><description>Juvenile dermatomyositis (JDM) is an autoimmune disease characterized by muscle weakness and specific skin lesions, as well as non‐muscular involvement such as interstitial lung disease (ILD), cardiac involvement and arthritis. Anti‐melanoma differentiation‐associated protein 5 (anti‐MDA5)‐positive JDM patients are typically characterized by the presence of skin ulcers and rapidly progressing ILD (RP‐ILD). Although cardiac involvement is not an expected involvement in anti‐MDA5‐positive JDM cases, it is significant because it can be fatal. In this report, an anti‐MDA5 myositis‐specific autoantibody‐positive JDM case referred with the diagnosis of psoriatic arthritis in whom cardiomyopathy and arrhythmia were detected in follow‐up is presented. Since cardiac involvement is associated with mortality, it would be useful to follow up anti‐MDA5 positive patients for cardiac involvement in addition to lung involvement. Tofacitinib is a promising treatment option in treatment‐resistant JDM.</description><subject>anti‐MDA5</subject><subject>Arrhythmia</subject><subject>Autoantibodies</subject><subject>Autoimmune diseases</subject><subject>cardiac involvement</subject><subject>Cardiomyopathy</subject><subject>Coronary artery disease</subject><subject>Dermatomyositis</subject><subject>Heart diseases</subject><subject>juvenile dermatomyositis</subject><subject>Lung diseases</subject><subject>Melanoma</subject><subject>Myositis</subject><subject>Psoriatic arthritis</subject><subject>Skin diseases</subject><subject>Skin lesions</subject><subject>Ulcers</subject><issn>1756-1841</issn><issn>1756-185X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkLtOwzAUhi0EolCY2ZAl5rS-Ju5YVdykSjCAxGY5sS1cNXGxk1bdWNh5Rp4E90JXvPgc6z_fsT4ArjAa4HSGuOB5hgV_G2CWU3QEzg4vx4ea4R44j3GGUI5pXpyCHs0FJ6LgZ-BrooJ2qoKuWfr50tSmaVMNFaxUNNBbOOuWpnFzA7UJtWp9vfbRtS7ClWvf4WLbLA1UTet-Pr9rM1eNrxXUzloTEs2p1vkEjNFXqTYaLoJvTdrBt0Ol1-sLcGLVPJrL_d0Hr3e3L5OHbPp0_zgZT7OKUoEySixWQiHFGdMEWcyV4JZQPrIWE6R1ITAtyQhxwUc5YgIxIoguK2xRwSijfXCz46YvfHQmtnLmu9CklZIIxjAjpEApNdylquBjDMbKRXC1CmuJkdxolxuxciNZbrWnies9tytrow_5P88pwHeBVTK5_o8nx8_THfgXKyqPIg</recordid><startdate>202308</startdate><enddate>202308</enddate><creator>Kaplan, Melike Mehveş</creator><creator>Çelikel, Elif</creator><creator>Güngörer, Vildan</creator><creator>Ekici Tekin, Zahide</creator><creator>Gürsu, Hazım Alper</creator><creator>Polat, Sanem Eryılmaz</creator><creator>Cinel, Güzin</creator><creator>Çelikel Acar, Banu</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><orcidid>https://orcid.org/0000-0003-0129-4410</orcidid><orcidid>https://orcid.org/0000-0003-2309-7952</orcidid><orcidid>https://orcid.org/0000-0002-6209-196X</orcidid><orcidid>https://orcid.org/0000-0002-0707-2678</orcidid><orcidid>https://orcid.org/0000-0002-5446-667X</orcidid><orcidid>https://orcid.org/0000-0002-8012-2774</orcidid><orcidid>https://orcid.org/0000-0002-9838-2603</orcidid><orcidid>https://orcid.org/0000-0002-1808-3655</orcidid></search><sort><creationdate>202308</creationdate><title>Cardiac involvement in a case of juvenile dermatomyositis with positive anti‐melanoma differentiation associated protein 5 antibody</title><author>Kaplan, Melike Mehveş ; Çelikel, Elif ; Güngörer, Vildan ; Ekici Tekin, Zahide ; Gürsu, Hazım Alper ; Polat, Sanem Eryılmaz ; Cinel, Güzin ; Çelikel Acar, Banu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3380-32f1a8a0a544d20f15a85f2359ff120dd7813b2905859604804282dbc1f074343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>anti‐MDA5</topic><topic>Arrhythmia</topic><topic>Autoantibodies</topic><topic>Autoimmune diseases</topic><topic>cardiac involvement</topic><topic>Cardiomyopathy</topic><topic>Coronary artery disease</topic><topic>Dermatomyositis</topic><topic>Heart diseases</topic><topic>juvenile dermatomyositis</topic><topic>Lung diseases</topic><topic>Melanoma</topic><topic>Myositis</topic><topic>Psoriatic arthritis</topic><topic>Skin diseases</topic><topic>Skin lesions</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaplan, Melike Mehveş</creatorcontrib><creatorcontrib>Çelikel, Elif</creatorcontrib><creatorcontrib>Güngörer, Vildan</creatorcontrib><creatorcontrib>Ekici Tekin, Zahide</creatorcontrib><creatorcontrib>Gürsu, Hazım Alper</creatorcontrib><creatorcontrib>Polat, Sanem Eryılmaz</creatorcontrib><creatorcontrib>Cinel, Güzin</creatorcontrib><creatorcontrib>Çelikel Acar, Banu</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>International journal of rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaplan, Melike Mehveş</au><au>Çelikel, Elif</au><au>Güngörer, Vildan</au><au>Ekici Tekin, Zahide</au><au>Gürsu, Hazım Alper</au><au>Polat, Sanem Eryılmaz</au><au>Cinel, Güzin</au><au>Çelikel Acar, Banu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiac involvement in a case of juvenile dermatomyositis with positive anti‐melanoma differentiation associated protein 5 antibody</atitle><jtitle>International journal of rheumatic diseases</jtitle><addtitle>Int J Rheum Dis</addtitle><date>2023-08</date><risdate>2023</risdate><volume>26</volume><issue>8</issue><spage>1582</spage><epage>1585</epage><pages>1582-1585</pages><issn>1756-1841</issn><eissn>1756-185X</eissn><abstract>Juvenile dermatomyositis (JDM) is an autoimmune disease characterized by muscle weakness and specific skin lesions, as well as non‐muscular involvement such as interstitial lung disease (ILD), cardiac involvement and arthritis. Anti‐melanoma differentiation‐associated protein 5 (anti‐MDA5)‐positive JDM patients are typically characterized by the presence of skin ulcers and rapidly progressing ILD (RP‐ILD). Although cardiac involvement is not an expected involvement in anti‐MDA5‐positive JDM cases, it is significant because it can be fatal. In this report, an anti‐MDA5 myositis‐specific autoantibody‐positive JDM case referred with the diagnosis of psoriatic arthritis in whom cardiomyopathy and arrhythmia were detected in follow‐up is presented. Since cardiac involvement is associated with mortality, it would be useful to follow up anti‐MDA5 positive patients for cardiac involvement in addition to lung involvement. Tofacitinib is a promising treatment option in treatment‐resistant JDM.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36852875</pmid><doi>10.1111/1756-185X.14630</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-0129-4410</orcidid><orcidid>https://orcid.org/0000-0003-2309-7952</orcidid><orcidid>https://orcid.org/0000-0002-6209-196X</orcidid><orcidid>https://orcid.org/0000-0002-0707-2678</orcidid><orcidid>https://orcid.org/0000-0002-5446-667X</orcidid><orcidid>https://orcid.org/0000-0002-8012-2774</orcidid><orcidid>https://orcid.org/0000-0002-9838-2603</orcidid><orcidid>https://orcid.org/0000-0002-1808-3655</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1756-1841
ispartof International journal of rheumatic diseases, 2023-08, Vol.26 (8), p.1582-1585
issn 1756-1841
1756-185X
language eng
recordid cdi_proquest_journals_2844142270
source Wiley
subjects anti‐MDA5
Arrhythmia
Autoantibodies
Autoimmune diseases
cardiac involvement
Cardiomyopathy
Coronary artery disease
Dermatomyositis
Heart diseases
juvenile dermatomyositis
Lung diseases
Melanoma
Myositis
Psoriatic arthritis
Skin diseases
Skin lesions
Ulcers
title Cardiac involvement in a case of juvenile dermatomyositis with positive anti‐melanoma differentiation associated protein 5 antibody
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T13%3A35%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiac%20involvement%20in%20a%20case%20of%20juvenile%20dermatomyositis%20with%20positive%20anti%E2%80%90melanoma%20differentiation%20associated%20protein%205%20antibody&rft.jtitle=International%20journal%20of%20rheumatic%20diseases&rft.au=Kaplan,%20Melike%20Mehve%C5%9F&rft.date=2023-08&rft.volume=26&rft.issue=8&rft.spage=1582&rft.epage=1585&rft.pages=1582-1585&rft.issn=1756-1841&rft.eissn=1756-185X&rft_id=info:doi/10.1111/1756-185X.14630&rft_dat=%3Cproquest_cross%3E2844142270%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3380-32f1a8a0a544d20f15a85f2359ff120dd7813b2905859604804282dbc1f074343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2844142270&rft_id=info:pmid/36852875&rfr_iscdi=true